• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹氟沙星给药方案对肉牛胃肠道药代动力学和粪便微生物组的影响。

Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers.

机构信息

Department of Population Health and Pathobiology, College of Veterinary Medicine, NC State University, Raleigh, NC, USA.

Department of Clinical Sciences, College of Veterinary Medicine, NC State University, Raleigh, NC, USA.

出版信息

Sci Rep. 2021 May 27;11(1):11249. doi: 10.1038/s41598-021-90647-z.

DOI:10.1038/s41598-021-90647-z
PMID:34045586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8160337/
Abstract

Fluoroquinolones are a class of antimicrobial commonly used in human medicine, and deemed critical by the World Health Organization. Nonetheless, two formulations are approved for the treatment of respiratory disease in beef cattle. The objective of this study was to determine the gastrointestinal pharmacokinetics and impact on enteric bacteria of cattle when receiving one of the two dosing regimens (high: 40 mg/kg SC once or low: 20 mg/kg IM q48hr) of danofloxacin, a commonly utilized synthetic fluoroquinolone in veterinary medicine. Danofloxacin was administered to 12 steers (age 7 months) fitted with intestinal ultrafiltration devices at two different dosing regimens to assess the gastrointestinal pharmacokinetics, the shifts in the gastrointestinal microbiome and the development of resistant bacterial isolates. Our results demonstrated high intestinal penetration of danofloxacin for both dosing groups, as well as, significant differences in MIC values for E. coli and Enterococcus between dosing groups at selected time points over a 38 day period. Danofloxacin treatment consistently resulted in the Euryarchaeota phyla decreasing over time, specifically due to a decrease in Methanobrevibacter. Although microbiome differences were minor between dosing groups, the low dose group had a higher number of isolates with MIC values high enough to cause clinically relevant resistance. This information would help guide veterinarians as to appropriate dosing schemes to minimize the spread of antimicrobial resistance.

摘要

氟喹诺酮类药物是一类在人类医学中常用的抗菌药物,被世界卫生组织视为关键药物。然而,有两种制剂被批准用于治疗肉牛的呼吸道疾病。本研究的目的是确定当牛接受两种达氟沙星(一种常用于兽医的合成氟喹诺酮)剂量方案(高剂量:40mg/kg SC 一次或低剂量:20mg/kg IM q48hr)之一时,其胃肠道药代动力学和对肠道细菌的影响。将达氟沙星给予 12 头安装有肠道超滤装置的阉牛,采用两种不同的剂量方案,以评估胃肠道药代动力学、胃肠道微生物组的变化以及耐药细菌分离株的产生。我们的研究结果表明,两种剂量组的达氟沙星均具有较高的肠道穿透性,并且在 38 天的时间内,在选定的时间点,大肠杆菌和肠球菌的 MIC 值在剂量组之间存在显著差异。达氟沙星治疗导致 Euryarchaeota 门的数量随着时间的推移而减少,特别是由于 Methanobrevibacter 的减少。尽管剂量组之间的微生物组差异较小,但低剂量组有更多的分离株具有足够高的 MIC 值,导致临床上相关的耐药性。这些信息将有助于指导兽医制定适当的剂量方案,以最大程度地减少抗菌药物耐药性的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/dc505f306fca/41598_2021_90647_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/2a3450deb94e/41598_2021_90647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/d82184de4e64/41598_2021_90647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/0ffffb5c11de/41598_2021_90647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/91cc3d967f4e/41598_2021_90647_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/57a286a63a53/41598_2021_90647_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/a3bb20475ac3/41598_2021_90647_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/b34e3082970c/41598_2021_90647_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/114b151f5677/41598_2021_90647_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/dc505f306fca/41598_2021_90647_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/2a3450deb94e/41598_2021_90647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/d82184de4e64/41598_2021_90647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/0ffffb5c11de/41598_2021_90647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/91cc3d967f4e/41598_2021_90647_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/57a286a63a53/41598_2021_90647_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/a3bb20475ac3/41598_2021_90647_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/b34e3082970c/41598_2021_90647_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/114b151f5677/41598_2021_90647_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/8160337/dc505f306fca/41598_2021_90647_Fig9_HTML.jpg

相似文献

1
Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers.丹氟沙星给药方案对肉牛胃肠道药代动力学和粪便微生物组的影响。
Sci Rep. 2021 May 27;11(1):11249. doi: 10.1038/s41598-021-90647-z.
2
Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers.头孢噻呋制剂会使牛肠道内药物浓度、粪便大肠杆菌耐药性和微生物组产生差异。
PLoS One. 2019 Oct 4;14(10):e0223378. doi: 10.1371/journal.pone.0223378. eCollection 2019.
3
Comparison of the Intestinal Pharmacokinetics of Two Different Florfenicol Dosing Regimens and Its Impact on the Prevalence and Phenotypic Resistance of and over Time.两种不同氟苯尼考给药方案的肠道药代动力学比较及其对[具体细菌名称1]和[具体细菌名称2]的流行率和表型耐药性随时间的影响。 (原文中“and”前后缺少具体内容,翻译时保留了原文结构,实际应用中需补充完整相关信息)
Microorganisms. 2021 Aug 30;9(9):1835. doi: 10.3390/microorganisms9091835.
4
Impact of Low and High Doses of Marbofloxacin on the Selection of Resistant Enterobacteriaceae in the Commensal Gut Flora of Young Cattle: Discussion of Data from 2 Study Populations.低剂量和高剂量的麻保沙星对犊牛共生肠道菌群中耐药肠杆菌科细菌选择的影响:来自2个研究群体的数据讨论
Foodborne Pathog Dis. 2017 Mar;14(3):152-159. doi: 10.1089/fpd.2016.2176. Epub 2017 Jan 10.
5
Research Note: Epidemiological cutoff values and acquired resistance mechanisms of three veterinary antibiotics against Escherichia coli from chicken respiratory tract infections.研究报告:三种兽医抗生素对鸡呼吸道感染大肠杆菌的流行病学截断值和获得性耐药机制。
Poult Sci. 2021 Feb;100(2):1093-1097. doi: 10.1016/j.psj.2020.11.049. Epub 2020 Nov 30.
6
Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf.达氟沙星在犊牛体内的药代动力学-药效学整合
Res Vet Sci. 2003 Jun;74(3):247-59. doi: 10.1016/s0034-5288(03)00005-5.
7
In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials.禽源大肠杆菌和多杀性巴氏杆菌对达氟沙星及其他五种抗菌药物的体外敏感性
Avian Dis. 1992 Oct-Dec;36(4):964-7.
8
New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.针对与牛呼吸道疾病相关的溶血曼氏杆菌和多杀性巴氏杆菌的达氟沙星抗菌药敏试验的新解释标准。
J Vet Diagn Invest. 2017 Mar;29(2):224-227. doi: 10.1177/1040638716683212. Epub 2017 Jan 8.
9
Evaluation of feeding distiller's grains, containing virginiamycin, on antimicrobial susceptibilities in fecal isolates of Enterococcus and Escherichia coli and prevalence of resistance genes in cattle.评估含有维吉尼亚霉素的酒糟对牛粪便中肠球菌和大肠杆菌分离株抗菌药物敏感性及耐药基因流行情况的影响。
J Anim Sci. 2014 Mar;92(3):1144-9. doi: 10.2527/jas.2013-6954. Epub 2014 Feb 3.
10
Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers.恩诺沙星给药方案对犊牛肠道药代动力学及粪便微生物群的影响。
Front Microbiol. 2018 Sep 19;9:2190. doi: 10.3389/fmicb.2018.02190. eCollection 2018.

引用本文的文献

1
Effect of Antimicrobial Use in Conventional Versus Natural Cattle Feedlots on the Microbiome and Resistome.传统与天然肉牛饲养场中抗菌药物使用对微生物组和耐药组的影响。
Microorganisms. 2023 Dec 14;11(12):2982. doi: 10.3390/microorganisms11122982.
2
Factors associated with antimicrobial resistant enterococci in Canadian beef cattle: A scoping review.加拿大肉牛中与耐抗菌药肠球菌相关的因素:一项范围综述。
Front Vet Sci. 2023 Apr 20;10:1155772. doi: 10.3389/fvets.2023.1155772. eCollection 2023.
3
Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves.

本文引用的文献

1
Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers.头孢噻呋制剂会使牛肠道内药物浓度、粪便大肠杆菌耐药性和微生物组产生差异。
PLoS One. 2019 Oct 4;14(10):e0223378. doi: 10.1371/journal.pone.0223378. eCollection 2019.
2
Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers.恩诺沙星给药方案对犊牛肠道药代动力学及粪便微生物群的影响。
Front Microbiol. 2018 Sep 19;9:2190. doi: 10.3389/fmicb.2018.02190. eCollection 2018.
3
Exact sequence variants should replace operational taxonomic units in marker-gene data analysis.
比较丹诺沙星和恩诺沙星在健康和感染溶血曼海姆菌的犊牛中的血浆和粪便药代动力学。
Sci Rep. 2022 Mar 24;12(1):5107. doi: 10.1038/s41598-022-08945-z.
在标记基因数据分析中,精确序列变体应取代操作分类单元。
ISME J. 2017 Dec;11(12):2639-2643. doi: 10.1038/ismej.2017.119. Epub 2017 Jul 21.
4
Comparative genomics of Enterococcus spp. isolated from bovine feces.从牛粪中分离出的肠球菌属的比较基因组学。
BMC Microbiol. 2017 Mar 8;17(1):52. doi: 10.1186/s12866-017-0962-1.
5
New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.针对与牛呼吸道疾病相关的溶血曼氏杆菌和多杀性巴氏杆菌的达氟沙星抗菌药敏试验的新解释标准。
J Vet Diagn Invest. 2017 Mar;29(2):224-227. doi: 10.1177/1040638716683212. Epub 2017 Jan 8.
6
DADA2: High-resolution sample inference from Illumina amplicon data.DADA2:从Illumina扩增子数据进行高分辨率样本推断。
Nat Methods. 2016 Jul;13(7):581-3. doi: 10.1038/nmeth.3869. Epub 2016 May 23.
7
Mechanisms of drug resistance: quinolone resistance.耐药机制:喹诺酮耐药性
Ann N Y Acad Sci. 2015 Sep;1354(1):12-31. doi: 10.1111/nyas.12830. Epub 2015 Jul 17.
8
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.粪便微生物群移植可消除复发性疾病小鼠模型中的艰难梭菌。
Infect Immun. 2015 Oct;83(10):3838-46. doi: 10.1128/IAI.00459-15. Epub 2015 Jul 13.
9
Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria.恩诺沙星和头孢噻呋在犊牛皮下注射后血浆、组织间液和胃肠道中的药代动力学,以及对代表性肠道细菌的杀菌作用。
J Vet Pharmacol Ther. 2016 Feb;39(1):62-71. doi: 10.1111/jvp.12236. Epub 2015 May 18.
10
Pharmacokinetic/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: comparison of bactericidal activity at the gut versus the systemic level in a pig model.氟喹诺酮类药物肠外给药对肠道微生物群影响的药代动力学/药效学评估:猪模型中肠道与全身水平杀菌活性的比较。
Int J Antimicrob Agents. 2013 Nov;42(5):429-35. doi: 10.1016/j.ijantimicag.2013.07.008. Epub 2013 Aug 19.